Target intelligence / Profile preview

General cellular components in seborrheic keratosis lesions

Molecular classification
Other
01

Overview

Seborrheic keratosis (SK) is a common, benign skin tumor characterized by the clonal proliferation of epidermal keratinocytes [1]. These lesions typically present as well-demarcated, "stuck-on" pigmented plaques and are composed of a variety of cellular components, including basaloid cells, squamous cells, and melanocytes [2]. While not a single molecular target, SK lesions are often driven by somatic mutations in the Fibroblast Growth Factor Receptor 3 (FGFR3) and the PIK3CA gene [3]. Pharmacological treatment, such as high-concentration topical hydrogen peroxide (40%), targets the lesion's general cellular structure through non-specific oxidative damage, leading to localized tissue necrosis and sloughing [4]. Because "general cellular components" refers to the entire pathological tissue rather than a specific protein or pathway, it is classified as a disease state or lesion rather than a canonical therapeutic target [5]. Understanding the cellular makeup of these lesions is crucial for distinguishing them from malignant mimics like melanoma or basal cell carcinoma [1]. Sources: [1] StatPearls, Seborrheic Keratosis; [2] PubMed, Pathogenesis of seborrheic keratosis; [3] Journal of Investigative Dermatology, FGFR3 and PIK3CA mutations in SK; [4] FDA, Eskata Prescribing Information; [5] American Academy of Dermatology, Seborrheic Keratosis Overview.

Other names
Seborrheic keratosis tissueSK lesion componentsSeborrheic verruca components
02

Mechanism of action

Induction of localized oxidative damage and tissue necrosis

03

Biological functions

Cell proliferationKeratinizationMelanogenesis
04

Disease associations

Seborrheic keratosis
05

Safety considerations

Skin irritationErythemaScarringPost-inflammatory hyperpigmentationHypopigmentation
06

Interacting drugs

Hydrogen peroxide
07

Biomarkers

Fibroblast growth factor receptor 3 (FGFR3) mutationPhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutation

Beyond the preview

Go deeper on General cellular components in seborrheic keratosis lesions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular components in seborrheic keratosis lesions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call